(19)
(11) EP 1 756 144 A2

(12)

(88) Date of publication A3:
16.02.2006

(43) Date of publication:
28.02.2007 Bulletin 2007/09

(21) Application number: 05750662.8

(22) Date of filing: 17.05.2005
(51) International Patent Classification (IPC): 
C07K 14/00(2006.01)
C07H 21/04(2006.01)
C12P 21/06(2006.01)
C07K 16/00(2006.01)
G01N 33/53(2006.01)
(86) International application number:
PCT/US2005/017356
(87) International publication number:
WO 2005/113572 (01.12.2005 Gazette 2005/48)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 19.05.2004 US 572634 P

(71) Applicant: Merck & Co., Inc.
Rahway, NJ 07065-0907 (US)

(72) Inventors:
  • BRANDISH, Philip, E.
    Rahway, New Jersey 07065-0907 (US)
  • ACTON, Paul, J.
    Rahway, New Jersey 07065-0907 (US)
  • WEI, Nan
    Rahway, New Jersey 07065-0907 (US)

(74) Representative: Man, Jocelyn et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU
Hertfordshire, EN11 9BU (GB)

   


(54) ISOLATED NUCLEIC ACID MOLECULES ENCODING A NOVEL PHOSPHOPROTEIN-DARPP-32, ENCODED PROTEIN AND USES THEREOF